Shares of Evotec SE (ETR:EVT – Get Free Report) rose 0.9% on Thursday . The stock traded as high as €8.10 ($8.44) and last traded at €8.00 ($8.33). Approximately 382,704 shares changed hands during mid-day trading, a decline of 72% from the average daily volume of 1,360,000 shares. The stock had previously closed at €7.93 ($8.26).
Evotec Price Performance
The business’s 50 day moving average is €8.67 and its two-hundred day moving average is €7.57. The firm has a market capitalization of $1.42 billion, a PE ratio of -8.33, a P/E/G ratio of 0.98 and a beta of 1.05. The company has a debt-to-equity ratio of 46.81, a current ratio of 1.83 and a quick ratio of 2.97.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Read More
- Five stocks we like better than Evotec
- Stock Market Upgrades: What Are They?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- How Investors Can Find the Best Cheap Dividend Stocks
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
